We are live on
!
Find out more
DCM
Deuterium Capital Management Portfolio holdings
AUM
$92.4M
1-Year Est. Return
35%
This Fund
S&P 500
This Quarter
Est. Return
+17.84%
1 Year Est. Return
+35%
3 Year Est. Return
+225.29%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$63.8M
AUM Growth
+$26.1M
(+69%)
Cap. Flow
+$20.1M
Cap. Flow
% of AUM
31.45%
Top 10 Holdings %
Top 10 Hldgs %
45.93%
Holding
107
New
42
Increased
29
Reduced
5
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$2.77M |
| 2 |
Cheniere Energy
LNG
|
+$1.81M |
| 3 |
Linde
LIN
|
+$1.42M |
| 4 |
Procter & Gamble
PG
|
+$1.12M |
| 5 |
Infosys
INFY
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.92M |
| 2 |
UnitedHealth
UNH
|
+$1.01M |
| 3 |
Johnson & Johnson
JNJ
|
+$848K |
| 4 |
Eli Lilly
LLY
|
+$660K |
| 5 |
Pfizer
PFE
|
+$541K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.43% |
| 2 | Energy | 13.64% |
| 3 | Consumer Staples | 11.93% |
| 4 | Materials | 11.62% |
| 5 | Financials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Moderna
MRNA
$23.6B
| – | – |
-1,500
| Closed | -$269K |
|
|
102
Pfizer
PFE
$153B
| – | – |
-10,565
| Closed | -$541K |
|
103
CALL
Invesco QQQ Trust
QQQ
$481B
| – | – |
-200
| Closed | -$200 |
|
104
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| – | – |
-360
| Closed | -$155K |
|
105
Thermo Fisher Scientific
TMO
$220B
| – | – |
-782
| Closed | -$431K |
|
|
106
UnitedHealth
UNH
$370B
| – | – |
-1,905
| Closed | -$1.01M |
|
107
Valero Energy
VLO
$85.9B
| – | – |
-2,894
| Closed | -$367K |
|
Similar funds
AW
ACMC
KA
MA
SSCM
ITG
KAM
MRP
Deuterium Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Deuterium Capital Management held 107 positions worth $63.8M, up 69% from $37.7M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Deuterium Capital Management deployed $20.1M of net new capital in Q1 2023, opening 42 new positions and adding to 29 existing holdings. Its largest new stake was TSMC: 30,909 shares worth $2.88M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Energy and Consumer Staples.
On the sell side, the largest reduction was NVIDIA, an estimated $2.92M trimmed.
- Deuterium Capital Management's largest Q1 2023 buy was TSMC: 30,909 shares worth $2.88M.
- Deuterium Capital Management added most to Procter & Gamble in Q1 2023, an estimated $1.12M increase.
- Deuterium Capital Management's biggest Q1 2023 reduction was NVIDIA, cutting an estimated $2.92M.
- Deuterium Capital Management fully exited UnitedHealth in Q1 2023, selling an estimated $1.01M.
- Deuterium Capital Management's ten largest holdings make up 46% of its $63.8M portfolio in Q1 2023.
- Deuterium Capital Management opened 42 new positions and closed 17 in Q1 2023.
- Deuterium Capital Management's portfolio value rose 69% quarter-over-quarter to $63.8M.
Based on Deuterium Capital Management's 13F filing for Q1 2023, filed 12 May 2023.